Combination of respiratory electron transport chain inhibitors with a cytochrome bd inhibitor
US10799494B2 · kind B2 · utility
0Cited by
0References
12Claims
0Family size
Inventors
Key dates
| Filing date | Dec 16, 2016 |
| Grant date | Oct 13, 2020 |
| Priority date | — |
| Expiry date | Dec 16, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a combination therapeutic product comprising one or more respiratory electron transport chain inhibitors and a cytochrome bd inhibitor, as defined herein, or a pharmaceutically acceptable salt thereof. The present invention also relates to pharmaceutical compositions comprising the combination therapeutic product and to the use of the combination therapeutic product in the treatment of mycobacterial infections, such as tuberculosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.